Brief: Infinity Pharmaceuticals Reports Q2 Loss Per Share Of $0.13
27/07/2021 14:46
July 27 (Reuters) - Infinity Pharmaceuticals Inc INFI.O :
* INFINITY PHARMACEUTICALS REPORTS SECOND QUARTER 2021
FINANCIAL
RESULTS AND PROVIDES COMPANY UPDATE
* Q2 LOSS PER SHARE $0.13
* Q2 EARNINGS PER SHARE ESTIMATE $-0.14 -- REFINITIV IBES
DATA
* EXPECTS NET LOSS FOR 2021 TO RANGE FROM $40 MILLION TO $50
MILLION
* INFINITY PHARMA - EXPECTS TO END 2021 WITH YEAR-END-CASH,
CASH
EQUIVALENTS,AVAILABLE FOR SALE SECURITIES BALANCE RANGING FROM
$70 MILLION TO $80 MILLION
Source text for Eikon: ID:nBw2QNP3ya
Further company coverage: INFI.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Infinity Pharmaceuticals
See all newsBrief: Infinity Pharmaceuticals Filed Voluntary Petition For Relief Under Provisions Of Chapter 11
Brief: Infinity Pharmaceuticals Inc Received Determination Letter From Nasdaq On September 12
Brief: Infinity Pharma Says On Sept 5, 2023, Co Received Letter From Nasdaq Notifying That Listing Of Common Stock Was Not In Compliance With Nasdaq Listing Rule
Brief: Infinity Pharmaceuticals Approved Plan To Reduce Co's Overall Headcount By 21 Positions
U.S. STOCKS ON THE MOVE-General Motors, Estee Lauder, IMAX